Vascular Surgery Admissions in a Tertiary Care Hospital in the Mid-West: A 12 Month Profile.

November 28, 2023 updated by: Fiona Leahy, University Hospital of Limerick
Creating a 12 month profile of Vascular Surgery Admissions aims to inform service delivery and optimise patient care resources. There is a gap in the literature pertaining to this topic, particularly from an Irish perspective. This research could inform a clinical pathway to reduce LOS for patients cared for by the Department of Vascular Surgery.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

This is an observational cross sectional study. This study will be mixed methods. Following the profile creation the researcher aims to complete qualitative research in the form of interviewing a cohort of vascular patients about their experiences in order to inform practice development. Ethics approval will be granted prior to any activities taking place.

Selection/Recruitment:

Patients attending UHL deemed to have vascular care needs and assigned to the care of a Vascular Consultant will be included in this study. The data will be collected 12 months from the date of commencing the study. Vascular consults will be excluded for the purpose for this research unless care is transferred. Informed consent is not required for this research so there in no exclusion criteria in relation to ability to provide same.

Data Collection:

The data to inform this project will be collected from medical chart review and utilising the UHL inpatient IT systems. No patient identifiers will be collected for this research and it will comply with GDPR. The Ipims system will be used to measure current inpatients under the care of a Vascular Consultant. HIPE data will be requested to examine the length of stay for vascular inpatients. The individual's medical notes will be reviewed to assess:

  • Reason for admission to hospital and/or presentation to the Emergency Department (ED).
  • Date, day and time of admission.
  • Referral source.
  • Categorisation from triage in the ED if applicable.
  • Consultant caring for the individual.
  • Demographic profile & Brief Medical and Surgical History.
  • ? Elective or Emergency admission.
  • ? Intervention or conservative management. Treatment course.
  • ? Re-admission.
  • Length of stay.
  • Time patient waited for theatre procedure (date of admission to date of theatre) including fasting time.
  • Time patient waited for vascular scans (date of admission to date of scans) & scans completed.
  • Time patient waited for rehab (transfer) if applicable.
  • Time patient waited for OPAT if applicable.
  • Clinical Frailty Scale (Appendix II) & Charlson Co-Morbidity Scale (Appendix III) (no patient intervention required).

Data Analysis:

Descriptive statistics with multivariant analyses.

Process Evaluation:

The MRC Framework will be employed for process evaluation.

Study Type

Observational

Enrollment (Estimated)

650

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

This study aims to create a profile f vascular admissions to a tertiary care hospital in the Mid West of Ireland and describe the characteristics of the admission.

Description

Inclusion Criteria:

  • Patients attending UHL deemed to have vascular care needs and assigned to the care of a Vascular Consultant will be included in this study.
  • The data will be collected 12 months from the date of commencing the study.

Exclusion Criteria:

  • Patients outside of the set dates will be excluded.
  • Vascular consults will be excluded for the purpose of this research unless care is transferred.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Vascular Surgery Admissions
Patients who present and/or are admitted to University Hospital Limerick under the care of a Vascular Consultant.
It will be documented if the patient underwent surgery for their vascular issue

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical Frailty Scale
Time Frame: 1 year
Clinical frailty score will be determined for vascular patient admissions. This is a 9 point scale. the higher the score means the greater the risk.
1 year
Charlson Co-Morbidity Scale
Time Frame: 1 year
Scoring will be determined for vascular patient admissions. The Charlson Comorbidity Index (CCI) assesses comorbidity level by taking into account both the number and severity of 19 pre-defined comorbid conditions. It provides a weighted score of a client's comorbidities which can be used to predict short term and long-term outcomes such as function, hospital length of stay and mortality rates.
1 year
Admission details
Time Frame: 1 year
Length of stay, interventions, referral source will be documented
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 1, 2024

Primary Completion (Estimated)

July 1, 2025

Study Completion (Estimated)

September 1, 2025

Study Registration Dates

First Submitted

June 1, 2022

First Submitted That Met QC Criteria

June 21, 2022

First Posted (Actual)

June 27, 2022

Study Record Updates

Last Update Posted (Actual)

November 29, 2023

Last Update Submitted That Met QC Criteria

November 28, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • DVS001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The researcher will not be sharing IPD

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vascular Diseases

Clinical Trials on Surgery

3
Subscribe